The Munich chipmaker has spent the past month fighting on two fronts — in courtrooms and in the capital markets — and both campaigns are now producing tangible results.
Infineon’s legal offensive against Chinese rival Innoscience culminated on July 7 when the US International Trade Commission issued a final ruling confirming that Innoscience’s gallium-nitride products infringe an Infineon patent. The decision keeps import and sales bans in place across the United States. That verdict followed two earlier wins in Germany: on June 18 and July 3, the Munich Regional Court I found violations of both a patent and a utility model in the GaN space.
Three proceedings, three different judicial bodies, one consistent outcome. The symmetry suggests a patent portfolio robust enough to withstand scrutiny across jurisdictions — and a company willing to defend it aggressively.
Yet the picture flips entirely in China. The Supreme People’s Court upheld sales bans on Infineon’s GaN products on the mainland back in June, and in early July a Chinese court ordered Infineon to remove GaN products from its booth at the electronica China trade fair. The legal landscape is effectively a mirror image: Infineon wins in the West, loses at home.
That geopolitical split matters more than the legal minutiae suggest. Infineon has guided its AI power semiconductor business to more than €1.6 billion in revenue for the current fiscal year, with GaN technology a critical component — particularly for the high-efficiency power supplies that keep AI data centers running, an area Infineon has been developing alongside LS ELECTRIC. If Innoscience could undercut that franchise with cheaper, patent-infringing products in Western markets, the growth story would face a direct threat. The ITC and Munich rulings remove that risk in two of the most important markets.
A Buyback With Modest Ambitions
On the capital markets side, Infineon formalized the next tranche of its ongoing repurchase program on Monday. The company will buy back up to 3 million of its own shares, with a budget capped at €225 million within an original framework of up to €300 million. The program runs until November 13, 2026, and an independent credit institution has been mandated to handle the technical execution.
This is operational routine rather than a grand capital-return statement — the shares are earmarked for employee participation schemes. But it does signal that Infineon retains financial flexibility despite ongoing litigation and heavy investment commitments.
Should investors sell immediately? Or is it worth buying Infineon?
The buyback lands at a moment of renewed analyst enthusiasm. Goldman Sachs’ Alexander Duval reaffirmed his buy rating on Wednesday and lifted his price target from €88 to €91, citing accelerated AI-driven demand and a recovery in end markets. That puts Goldman at the upper end of current Street estimates.
Not every voice is equally bullish. Deutsche Bank trimmed its target from €90 to €85 in early August while keeping a “Buy” rating, with analyst Johannes Schaller pointing to one-off effects in manufacturing and inventory that weighed on profitability. The segment result margin of 19.1 percent in the third quarter did come in slightly below the 19.5 percent analysts had expected. Jefferies’ Janardan Menon, meanwhile, held firm with a €96 target and a buy recommendation, citing a constructive outlook for fiscal 2027.
Record Quarter, Recovering Cash Flow
The numbers behind the analyst chatter are strong. Infineon reported record third-quarter revenue of €4.17 billion, up 12.6 percent year over year, with earnings per share climbing from €0.23 to €0.32. Management raised its full-year revenue guidance to roughly €16.3 billion. Free cash flow swung to €599 million in the quarter, reversing a negative €63 million in the year-ago period — a swing that makes funding the buyback considerably easier without straining the balance sheet.
The share price has responded. The stock gained 2.21 percent on Wednesday to trade at €64.20, following Tuesday’s close of €62.81. That puts the weekly gain at 6.31 percent and the year-to-date advance at 70.16 percent. The stock has risen 2.9 percent since last Friday’s earnings release.
Still, the recovery has ground to cover. The shares remain 28.40 percent below their 52-week high of €89.67, and the primary article notes the stock sits below its 50-day average of €72.01 with annualized 30-day volatility of 68.49 percent. The market has celebrated the growth narrative, but the valuation remains prone to swings.
The broader takeaway is that Infineon is defending its technological moat with legal force while quietly returning capital to shareholders — a combination that should support pricing power in GaN over the medium term, even with the Chinese market effectively closed for now. Investors who read Infineon as merely another AI cycle play are missing the part of the story that may ultimately determine how durable the current growth rates really are.
Ad
Infineon Stock: Buy or Sell?! New Infineon Analysis from August 12 delivers the answer:
The latest Infineon figures speak for themselves: Urgent action needed for Infineon investors. Is it worth buying or should you sell? Find out what to do now in the current free analysis from August 12.
Infineon: Buy or sell? Read more here...








